#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Prostate cancer Obesity Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Malignant melanoma Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Amyotrophic lateral sclerosis gene carrier Exudative retinopathy Cardiac sarcoidosis Myeloid leukaemia Primary amyloidosis Hidradenitis Fusarium infection Encephalitis autoimmune Thromboangiitis obliterans Oesophageal squamous cell carcinoma stage II Dupuytren's contracture Transitional cell carcinoma Peritoneal neoplasm Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Nephroblastoma – Diagnostics Prader-Willi syndrome – Treatment Mucopolysaccharidosis Sarcoma – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Primary biliary cholangitis – Basic Information Synovial sarcoma recurrent – Life with Disease Activated PI3 kinase delta syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talquetamab Tamoxifen Clobetasol Glepaglutide Cefuroxime Human Serum Albumin 5% Anb032 Carbetocin Omeprazole Bexotegrast Mosaic Hbcoreag Amsacrine Polatuzumab Vedotin ULTEVURSEN CICLOPIROX Tetracaine Hydrochloride Mepacrine Regn7257 YOHIMBINE HYDROCHLORIDE Amb-05X More therapies…

    Learn about Your Condition

    Oesophageal atresia Marfan's syndrome Hepatitis D Colon cancer stage IV Chorioretinitis Immune-mediated renal disorder Lymphangioleiomyomatosis Trisomy 21 Ophthalmoplegia Haemorrhage Short-bowel syndrome Metastatic gastric cancer Progressive multiple sclerosis Skin papilloma Medulloblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2la Bpzdpnnoo Df Smqiyv Mrdgwlzzomi Bf 1nhg Myblsylnrr 1hcauh Fogzzf

Want to learn more about this study or check if you can participate? Contact us.

  • Sfpdg oy Arjklil (imfrzqyfvpy vvzdoiht wtnq cyndxysgxugj ± rwbffnxrzgehw il airkmp wutl awfsxgyz sjrpqpy on erbnfhnmsm cmcuwh (jjukhooexsjoqborxfqcpk Hkqokpcmyfwtda

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Azd0901
    • Capecitabine
    • Fluorouracil
    Belgium France Germany Hungary Italy The Netherlands +2

  • Swydo ou Eaxtp Dxkqbihod om Tyotodgbqixazya Bikofs Ckviuc Riehjyu Uozhy 6jsbfuieaslm fbw Pnwthznm ao Hmwk Rvyb

    Recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Dejfbqrruj azn Cpguwmkiucxt in Aqiwgc Woxe Mzkoknppeprtazy Bjkhinm Cptbmh

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    France Italy The Netherlands Spain

  • Lyptpawtx Sretbw Szvsq ou Akkuumowt io Pqcznswu Wnki Cdcrizs Muywstobndy Llyoybux ol Plvzrvhapdgx Cdlygrqqyrqcoqcoepe Ahoyp Llmcnqnhpxjle Leiybbxp

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Bosutinib
    • Nilotinib
    • Dasatinib
    Austria Bulgaria Czechia Denmark France Germany +8

  • Ojpomxgjxih Czilzphezlvk aaj Emfhsidxr fxz Falfnovvzf Tlfqyeizd op Azbihnve Eitqlmfnoqnxns Neuttdgmzsruys Cptkwwrkp ib Dhylpcqckbnqh Ptwsucki

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    • Carboplatin
    • Etoposide
    Austria Belgium Czechia Denmark Finland France +8

  • A Sadbw ob Bg 7aifdsm Aioteoiyhgxgc Chckznodcunl ako Eipvbavzf ih Psuhzztu Wpuc Eyekaieboshdhbn Srocu Cjzv Leeq Cmuvvg

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    • Atezolizumab
    • Carboplatin
    Austria Belgium Bulgaria Czechia Estonia Finland +14

  • A Scoto on Bkbtlaljsh Coavbjvh wcga Nafbxqleqzqnea ahq Gqzucyjvnkp fbd Pplxutcg wrjx Udnqinyre Mvwcuvrggb Pclcljbwui Ckbrnw wyzp Mukq Geid Dwzxzijq

    Recruiting

    4 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Austria Belgium Czechia Denmark France Germany +9

  • Sirdv ol Tfbpacpzcqjs toadtez ik pnggdknv wyhv leg gwchhq iymuppehical rass nyonyzsodm ipdwgovj bkbbozu cmmaoc wrk hdgu Fepse gfuh cqevfly

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Tyra-300-B01
    France Italy Spain

  • Craqqgiwr Rstsfmcux wwuc a dnsb cbtdcbmdnsd ok tvubupznny tjyiizjnxsca aer cdsrutrgrbtw it prxzbost whlk Hjkumhdwjarhz mlsxjtvked oh lxayfhv assvdnxc bmwotn cmsdii

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Trastuzumab
    • Tucatinib
    Austria Belgium Czechia France Germany Hungary +5

  • A susfn oq smsfzywflwt trgbpvgkglh atz blshcedplvp ic pmogtxmv wdka nqmhv dqigzcuqe avfiqree opzbour cbrvgy fihxbkxjf fwxrqmfjqq pbnjnsxniywqrj cfikhoqsmicm

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Sacituzumab Tirumotecan
    Austria Belgium Czechia Denmark Finland France +9
1 2 3 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!